Statistics for Intravitreal ranibizumab for myopic choroidal neovascularization: 12-month results
Total visits
| views | |
|---|---|
| Intravitreal ranibizumab for myopic choroidal neovascularization: 12-month results | 257 |
Total visits per month
| views | |
|---|---|
| August 2024 | 0 |
| September 2024 | 0 |
| October 2024 | 4 |
| November 2024 | 2 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
File Visits
| views | |
|---|---|
| Intravitreal.pdf(legacy) | 432 |
Top country views
| views | |
|---|---|
| United States | 148 |
| China | 53 |
| France | 11 |
| Russia | 10 |
| Germany | 9 |
| Canada | 7 |
| Poland | 4 |
| United Kingdom | 3 |
| Netherlands | 3 |
| Denmark | 2 |
| Portugal | 2 |
| Australia | 1 |
| Hong Kong SAR China | 1 |
| Saudi Arabia | 1 |
| Turkey | 1 |